Dishman Carbogen Amcis Ltd.

NSE: DCAL BSE: 540701 SECTOR: Pharmaceuticals & Drugs  34k   122   14

114.75
+1.15 (1.01%)
NSE: Today, 04:04 PM

Price Summary

Today's High

₹ 115.8

Today's Low

₹ 113.5

52 Week High

₹ 259.7

52 Week Low

₹ 97.4

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1799.09 Cr.

Enterprise Value

2275.04 Cr.

No. of Shares

15.68 Cr.

P/E

0

P/B

0.43

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  268.33

CASH

50.32 Cr.

DEBT

526.27 Cr.

Promoter Holding

59.32 %

EPS (TTM)

₹  -2.71

Sales Growth

-64.18%

ROE

-4.92 %

ROCE

-2.55%

Profit Growth

-704.39 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-64.18%
3 Year-24.03%
5 Year98.15%

Profit Growth

1 Year-704.39%
3 Year-284.5%
5 Year-404.45%

ROE%

1 Year-4.92%
3 Year-0.99%
5 Year-0.28%

ROCE %

1 Year-2.55%
3 Year0.57%
5 Year1.35%

Debt/Equity

0.1126

Price to Cash Flow

-1191.45

Interest Cover Ratio

-3.93678665496049

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2022 59.32 0
Mar 2022 59.32 0
Dec 2021 59.32 0
Sep 2021 59.32 0
Jun 2021 59.32 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a high promoter holding of 59.32%.

 Limitations

  • The company has shown a poor profit growth of -284.498574473703% for the Past 3 years.
  • The company has shown a poor revenue growth of -24.0324355172895% for the Past 3 years.
  • Company has a poor ROE of -0.988197986724589% over the past 3 years.
  • Company has a poor ROCE of 0.57183307417277% over the past 3 years
  • Company has low Interest coverage ratio of -3.93678665496049.
  • Company has high debtor days of 195.037498197202.
  • Company has negative cash flow from operations of -1.51.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
Net Sales 62.87 84.15 72.93 83.34 103.61
Total Expenditure 58.83 59.23 69.11 82.12 101.05
Operating Profit 4.04 24.92 3.82 1.22 2.56
Other Income 18.28 17.23 16.89 13.3 5
Interest 7.79 8.46 10.95 10.03 12.6
Depreciation 34.88 35.74 35.41 34.49 34.65
Exceptional Items 0 -2.5 0 -3.41 0
Profit Before Tax -20.35 -4.55 -25.65 -33.41 -39.69
Tax -6.83 -1.74 -6.02 -38.24 -14.86
Profit After Tax -13.52 -2.81 -19.63 4.83 -24.83
Adjusted EPS (Rs) -0.86 -0.18 -1.25 0.31 -1.58

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 451.49 474.46 549.47 580.74 208.01
Total Expenditure 303.36 315.57 355.68 407.18 265.47
Operating Profit 148.13 158.89 193.79 173.56 -57.46
Other Income 70.8 73.07 71.68 69.57 66.15
Interest 39.17 35.34 47.43 47.02 34.17
Depreciation 135.85 134.45 136.31 140.65 143.21
Exceptional Items 0 0 0 0 0
Profit Before Tax 43.91 62.17 81.73 55.46 -168.69
Tax 19.67 25.1 25.72 16.94 64.12
Net Profit 24.24 37.07 56.01 38.52 -232.81
Adjusted EPS (Rs.) 0 2.3 3.47 2.46 -14.85

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 0 32.28 32.28 31.38 31.36
Total Reserves 4770.74 4759.3 4860.09 4764.47 4643.26
Borrowings 144.62 279.37 202.73 137.9 144.41
Other N/C liabilities 220.33 372.43 195.08 356.7 348.96
Current liabilities 401.16 520.87 525.93 620.44 489.4
Total Liabilities 5536.85 5964.25 5816.11 5910.89 5657.39
Assets
Net Block 1927.08 1852.82 1715.32 1632.53 1509.65
Capital WIP 29.2 16.18 37.86 57.14 79.36
Intangible WIP 11.35 31.71 31.92 31.71 41.84
Investments 2593.82 2842.75 2886.97 2843.1 2814.87
Loans & Advances 191.96 462.42 406.44 576.27 529.06
Other N/C Assets 13.93 4.94 1.32 5.45 1.03
Current Assets 769.51 753.43 736.28 764.69 681.58
Total Assets 5536.85 5964.25 5816.11 5910.89 5657.39
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 43.91 62.17 81.73 55.46 -168.69
Adjustment 84.59 106.13 122.26 135.32 128.11
Changes in Assets & Liabilities 179.09 -122.65 -64.57 24.14 46.25
Tax Paid -37.21 -25.6 -19.69 -18.24 -7.18
Operating Cash Flow 270.38 20.05 119.73 196.68 -1.51
Investing Cash Flow -15.72 -174.61 -24.17 -74.3 62.07
Financing Cash Flow -225.38 142.45 -85.32 -124.07 -70.53
Net Cash Flow 29.28 -12.11 10.24 -1.69 -9.97

Corporate Actions

Investors Details

PARTICULARS Jun 2021% Sep 2021% Dec 2021% Mar 2022% Jun 2022%
Promoters 59.32 59.32 59.32 59.32 59.32
adimans technologi... 59.32 59.32 59.32 59.32 59.32
PARTICULARS Jun 2021% Sep 2021% Dec 2021% Mar 2022% Jun 2022%
Investors 40.68 40.68 40.68 40.68 40.68
icici prudential p... 1.41 1.26 - - -
l and t mutual fun... - - - - -
hbm healthcare inv... - 2.39 2.44 3.15 3.55
mukul mahavir agra... - - 3.19 3.25 3.25
tata mutual fund -... - - - - -
aditya birla sun l... - - - 3.03 2.76
idfc focused equit... - - - - -
l and t mutual fun... 2.90 2.90 2.90 2.52 2.52
mukul agrawal 2.55 2.87 - - -
government pension... 2.33 - - - -
aditya birla sun l... - - - - -
aditya birla sun l... 1.88 1.88 2.43 - -
hbm healthcare inv... 1.62 - - - -
jhunjhunwala rakes... 1.59 1.59 1.59 1.59 1.59
jhunjhunwala rekha... 1.59 1.59 1.59 1.59 1.59
llp 0.32 0.35 0.46 0.15 0.09
iepf - - 0.01 0.01 0.01

Annual Reports

Ratings & Research Reports

Company Presentations

  • ConcallQ4FY22 17 May 2022
  • PresentationQ1FY21 9 Sep 2020
  • PresentationQ2FY22 30 Oct 2021
  • PresentationQ4FY20 19 Jun 2020
  • PresentationQ1FY22 19 Aug 2021
  • PresentationQ2FY21 17 Nov 2020
  • PresentationQ4FY21 13 May 2021
  • PresentationQ3FY21 12 Feb 2021
  • PresentationQ3FY22 11 Feb 2022

Company News

Dishman Carbogen Amcis informs about conference call10 Aug 2022, 4:58PM Dishman Carbogen Amcis informs about investor presentation10 Aug 2022, 12:25PM Dishman Carbogen Amc - Quaterly Results9 Aug 2022, 6:39PM Dishman Carbogen Amc - Quaterly Results9 Aug 2022, 6:39PM Dishman Carbogen Amcis informs about closure of trading window28 Jun 2022, 3:35PM Dishman Carbogen Amcis informs about newspaper advertisement23 Jun 2022, 4:53PM Dishman Carbogen Amcis informs about annual secretarial compliance report30 May 2022, 1:50PM Dishman Carbogen Amc - Quaterly Results10 May 2022, 9:23PM Dishman Carbogen Amc - Quaterly Results10 May 2022, 9:23PM Dishman Carbogen Amc - Quaterly Results3 Feb 2022, 5:44PM Dishman Carbogen Amc - Quaterly Results3 Feb 2022, 5:44PM Dishman Carbogen Amc - Quaterly Results3 Feb 2022, 5:44PM Dishman Carbogen Amcis informs about compliances certificate10 Jan 2022, 1:45PM Dishman Carbogen Amcis informs about press release28 Oct 2021, 1:14PM Dishman Carbogen Amcis planning to invest $50 million in France to set up new facility 21 Oct 2021, 10:29AM Dishman Carbogen Amcis informs about confirmation certificate7 Oct 2021, 4:31PM Dishman Carbogen Amcis’ arm enters into co- investment agreement with European customers25 Aug 2021, 11:08AM Dishman Carbogen Amcis informs about conference call12 Aug 2021, 4:57PM Dishman Carbogen Amcis informs about confirmation certificate12 Jul 2021, 3:19PM Dishman Carbogen Amcis informs about analyst meet 26 May 2021, 4:05PM Dishman Carbogen Amcis unveils successful results on study that uncovers treatment for vitamin D deficiency 21 May 2021, 2:31PM Dishman Carbogen Amcis informs about non-applicability of large corporate entity17 May 2021, 2:01PM Dishman Carbogen Amcis informs about outcome of board meeting12 May 2021, 12:34PM Dishman Carbogen Amcis enters into agreement with Veritas10 May 2021, 11:26AM Dishman Carbogen Amcis’ arm enters into joint funding agreement with longstanding Japan based customer 29 Apr 2021, 10:58AM Dishman Carbogen Amcis’ arm declares new expansion plans in Switzerland, France14 Aug 2020, 10:24AM Dishman Carbogen Amcis informs about investor presentation4 Jun 2020, 3:57PM

Dishman Carbogen Amc Stock Price Analysis and Quick Research Report. Is Dishman Carbogen Amc an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Dishman Carbogen Amc and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs -1.51 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Dishman Carbogen Amc has a Debt to Equity ratio of 0.1126 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Dishman Carbogen Amc , the EPS growth was -704.772782360608 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Dishman Carbogen Amc has OPM of -27.6236719388491 % which is a bad sign for profitability.
     
  • ROE: Dishman Carbogen Amc have a poor ROE of -4.91654585252897 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Dishman Carbogen Amc

X